Randomized trials are also essential for device therapy
نویسندگان
چکیده
منابع مشابه
Blindness in Randomized Controlled Trials
In combination with randomization, blinding or masking is an important factor in randomized controlled trials (RCTs), particularly in trials that assess therapeutic effects. Here an attempt is made to explain blindness and why it is important. In clinical trials, blinding is defined as the condition imposed on a study in which study participants, health care providers and assessors collecting o...
متن کاملStem Cell Therapy for Parkinson’s disease: Are Double-Blind Randomized Control Trials the Best Design for Quantifying Therapy Outcomes?
The prevalence of brain disorders, in particular Parkinson’s disease [PD], stroke, and Alzheimer’s disease [AD] is expected to rise considerably associated with the increasing age of the populations of developed countries [1]. Therefore, it is essential to develop innovative and effective interventions which can be implemented to contain the burden of disease associated with brain disorders [2]...
متن کاملNot all randomized trials are equal.
he study by Beanlands et al. (1) in this issue of the Journal s a multicenter, randomized trial in 430 patients with oronary artery disease (CAD) and left ventricular ejection raction 35% to determine whether a management stratgy that included F-18-fluorodeoxyglucose (FDG) positron mission tomography (PET) imaging to guide revascularzation improved clinical outcomes compared with standard are w...
متن کاملAre distinctive ethical principles required for cluster randomized controlled trials?
Cluster randomized trials are increasingly used in research into health care and health services. Ethics of individual patient randomized trials have been elucidated in a number of different codes, but less attention has been given to the ethical issues raised by cluster randomized trials. I assess the challenges raised by cluster randomized controlled trials by considering three questions: Wha...
متن کاملOptimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials.
E ssential thrombocythemia (ET) and polycythemia vera (PV) are chronic myeloproliferative neoplasms (MPNs) associated with an increased risk of developing arterial and venous thrombotic events which are a major cause of early morbidity and mortality. 1,2 These MPNs frequently also evolve to myelofibrosis (MF) and less commonly a myelodysplastic syndrome (MDS) and/or transform to a universally f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Internal Medicine
سال: 2006
ISSN: 0954-6820,1365-2796
DOI: 10.1111/j.1365-2796.2006.01681.x